vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and MFA FINANCIAL, INC. (MFA). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $55.5M, roughly 1.5× MFA FINANCIAL, INC.). On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 9.2%).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
MFA Financial, Inc. is a U.S.-headquartered real estate investment trust (REIT) specializing in investing in and managing residential and commercial mortgage-backed securities, mortgage loans, and other real estate-related financial assets. It caters primarily to institutional and individual investors across the U.S., focusing on delivering stable risk-adjusted returns via rigorous asset screening and risk management frameworks.
BLLN vs MFA — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $55.5M |
| Net Profit | $5.7M | — |
| Gross Margin | 69.9% | — |
| Operating Margin | 11.5% | 97.9% |
| Net Margin | 6.8% | — |
| Revenue YoY | 117.4% | 9.2% |
| Net Profit YoY | 138.3% | — |
| EPS (diluted) | $0.10 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $55.5M | ||
| Q3 25 | $83.5M | $56.8M | ||
| Q2 25 | — | $61.3M | ||
| Q1 25 | — | $57.5M | ||
| Q4 24 | — | $50.8M | ||
| Q3 24 | $38.4M | $50.6M | ||
| Q2 24 | — | $53.5M | ||
| Q1 24 | — | $47.8M |
| Q4 25 | — | — | ||
| Q3 25 | $5.7M | $48.1M | ||
| Q2 25 | — | $33.2M | ||
| Q1 25 | — | $41.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-14.9M | $48.2M | ||
| Q2 24 | — | $41.9M | ||
| Q1 24 | — | $23.2M |
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 52.6% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 97.9% | ||
| Q3 25 | 11.5% | 84.5% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 70.0% | ||
| Q4 24 | — | 6.8% | ||
| Q3 24 | -32.9% | 98.2% | ||
| Q2 24 | — | 79.1% | ||
| Q1 24 | — | 50.7% |
| Q4 25 | — | — | ||
| Q3 25 | 6.8% | 84.7% | ||
| Q2 25 | — | 54.2% | ||
| Q1 25 | — | 71.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | -38.8% | 95.2% | ||
| Q2 24 | — | 78.4% | ||
| Q1 24 | — | 48.5% |
| Q4 25 | — | $0.43 | ||
| Q3 25 | $0.10 | $0.35 | ||
| Q2 25 | — | $0.21 | ||
| Q1 25 | — | $0.31 | ||
| Q4 24 | — | $-0.01 | ||
| Q3 24 | $-1.47 | $0.37 | ||
| Q2 24 | — | $0.32 | ||
| Q1 24 | — | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $213.2M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $1.8B |
| Total Assets | $327.5M | $13.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $213.2M | ||
| Q3 25 | $195.2M | $305.2M | ||
| Q2 25 | — | $275.7M | ||
| Q1 25 | — | $253.7M | ||
| Q4 24 | — | $338.9M | ||
| Q3 24 | — | $305.6M | ||
| Q2 24 | — | $289.4M | ||
| Q1 24 | — | $306.3M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $1.8B | ||
| Q3 25 | $-239.5M | $1.8B | ||
| Q2 25 | — | $1.8B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $1.8B | ||
| Q3 24 | $-242.9M | $1.9B | ||
| Q2 24 | — | $1.9B | ||
| Q1 24 | — | $1.9B |
| Q4 25 | — | $13.0B | ||
| Q3 25 | $327.5M | $12.1B | ||
| Q2 25 | — | $11.7B | ||
| Q1 25 | — | $11.5B | ||
| Q4 24 | — | $11.4B | ||
| Q3 24 | — | $11.2B | ||
| Q2 24 | — | $11.1B | ||
| Q1 24 | — | $10.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $76.2M |
| Free Cash FlowOCF − Capex | $6.5M | — |
| FCF MarginFCF / Revenue | 7.7% | — |
| Capex IntensityCapex / Revenue | 8.8% | — |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $76.2M | ||
| Q3 25 | $13.8M | $14.7M | ||
| Q2 25 | — | $38.5M | ||
| Q1 25 | — | $-14.6M | ||
| Q4 24 | — | $200.1M | ||
| Q3 24 | — | $-11.3M | ||
| Q2 24 | — | $46.5M | ||
| Q1 24 | — | $53.5M |
| Q4 25 | — | — | ||
| Q3 25 | $6.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 8.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | 0.31× | ||
| Q2 25 | — | 1.16× | ||
| Q1 25 | — | -0.35× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.23× | ||
| Q2 24 | — | 1.11× | ||
| Q1 24 | — | 2.30× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
MFA
Segment breakdown not available.
